Biotech | October 26, 2021
Biological E to receive US $ 50 million to boost Covid-19 vaccine capacity
Support from DFC will help produce one billion vaccine doses by the end of 2022
Support from DFC will help produce one billion vaccine doses by the end of 2022
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
The platform has seen an overall growth of 84% in the number of people seeking consultations for skin-related issues
The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit
Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Now all districts of the country will have commissioned PSA Oxygen plants
The transaction is anticipated to close in the first quarter of 2022
Subscribe To Our Newsletter & Stay Updated
